Login

Forgot your password?

Register

To create an account to access your personal
My Account OR Dashboard, click REGISTER below.

Register

New Provider Enrollment

To access on-line enrollment / new provider package, click ENROLL below.

Enroll

HEART CENTER - SERVICES & PROCEDURES


About The Center

Stony Brook University Heart Center
CONTACT INFO
Stony Brook University Heart Center
Health Sciences Drive
Stony Brook, NY 11794
SBU Heart Center Phone 631-44-HEART (444-3278)
SBU Heart Center Fax n/a
Map & Directions
Request an Appointment Request an Appointment

Services & Procedures

Minimally Invasive Program

Minimally invasive efforts in cardiac surgery involve procedures performed "off-pump"-without the use of cardiopulmonary bypass via heart-lung machine-or via small thoracic incisions. The result for patients: reduced pain, less need for postoperative pain medication, faster healing time, and smaller scars.

OFF-PUMP CORONARY ARTERY BYPASS: Frank C. Seifert, M.D., heads our minimally invasive bypass surgery program, which includes multi-vessel OPCAB (off-pump coronary artery bypass) and MIDCAB (minimally invasive direct coronary artery bypass). More than 2,000 of these off-pump procedures have been performed at Stony Brook, representing 50 percent of the coronary bypass surgeries performed here. We use endoscopic and radial vein harvesting for all of our patients undergoing bypass, for improved cosmetics, significantly reduced postoperative leg pain and complications, and faster recovery. read more

Da Vinci Da Vinci robotically-assisted CABG

 Back to Top

Minimally Invasive Valve Surgery

Sternotomy incisions are no longer an absolute requirement for valvular surgery. We perform minimally invasive mitral valve and aortic valve repair and replacement, with endoscopic techniques via small thoracotomy (chest) incisions. Most mitral valves are repaired rather than replaced. read more

 Back to Top

Thoracic Aortic Aneurysm (TAA)

TAA-a life-threatening bulge in the thoracic aorta, the major artery from the heart-affects an estimated 31,000 people each year in the United States. Allison J. McLarty, M.D., director of our thoracic aortic surgery program, and Thomas V. Bilfinger, M.D., director of our program in thoracic surgery, lead our minimally invasive aortic program that includes the use of stents placed through small incisions in the leg. This newer, safer approach replaces conventional surgery and its associated significant morbidity and mortality. Complex aortic and aortic arch reconstructions and hybrid elephant trunk repairs of the aortic arch are also performed by Stony Brook's cardiothoracic and vascular surgeons. read more

Da Vinci Thoracic Aortic Aneurysm (TAA)

 Back to Top

Maze Procedure

This highly specialized surgery for atrial fibrillation is available at only a few medical centers, including Stony Brook. A radiofrequency probe makes a series of lines ("maze") in the atrium. Normal electrical impulses travel through these pathways, overriding faulty impulses that cause chaotic and ineffective heartbeat. The surgery has a high success rate for sustaining normal heart rhythms, usually without the need for a pacemaker. read more

 Back to Top

Enhanced External Counterpulsation

Enhanced External Counterpulsation (EECP) is a noninvasive, nonsurgical treatment for intractable angina pectoris that was developed by a team including Harry Soroff, M.D., founding chair of Stony Brook's Department of Surgery. In 1989, Stony Brook researchers determined that EECP treatment continued to show helpful effects for patients as long as three years after completion of treatment. Today, the Heart Center at Stony Brook remains the premier location for this therapy. Cuffs similar to those used to measure blood pressure are placed on the patient's legs and sequentially inflated from calf to thigh. This gentle compression moves oxygen-enriched blood back to ischemic areas of the heart. The treatment relieves chronic angina pain and offers a therapeutic option for patients who are not candidates for angioplasty, stenting, or coronary artery bypass surgery. There are no reported risks of complication associated with this treatment, and EECP patients may even experience reduced need for medication. Recent studies show that EECP may also be beneficial for patients with stabilized congestive heart failure. read more

 Back to Top

Destination Therapy

Patients with advanced-stage heart failure will turn to Stony Brook for a new treatment that enables them to live independently at home. Destination therapy uses a portable, implantable "artificial heart" device that takes over the pumping function of the heart. The Thoratec HeartMate® eXtended Lead Vented Electric (XVE) device, used by Heart Center specialists, is the only left ventricular assist device approved by the Food and Drug Administration as permanent support for patients who do not respond to other therapies and are ineligible for cardiac transplantation. read more

 Back to Top

Cardiac Resynchronization

Cardiac resynchronization therapy (CRT) offers new hope for heart failure patients who have ventricular dysynchrony (a condition in which the ventricles do not contract together, which causes patients to experience marked shortness of breath and fatigue). This breakthrough treatment implants a pacemaker to deliver electrical impulses to the ventricles, restoring synchronous heart function. Standard pacemakers have only two leads that stimulate the right side of the heart, but the innovative CRT device has a third lead that extends into the left ventricle.

Correct placement of this left ventricular lead is critical to the treatment's success. Stony Brook electrophysiologists have achieved a left ventricular implant success rate of greater than 95 percent. Our cardiac resynchronization expertise has changed the lives of progressively deteriorating patients who previously could be managed only with drugs or surgical interventions.

 Back to Top

Catheter Ablation

Catheter ablation of atrial fibrillation requires precise anatomic information to place continuous radio-frequency ablation lesions around the pulmonary veins correctly, and to minimize complications (possible pulmonary vein stenosis). Importing a preoperative cardiac CT into the threedimensional (3-D) electrophysiology mapping system gives us a detailed anatomic reconstruction of the left atrium and pulmonary veins. The best candidates for this type of ablation are patients with symptomatic paroxysmal or persistent atrial fibrillation that is refractory to medical therapy.

Ventricular arrhythmias also are treated with ablation therapy. Rather than keep a patient in sustained tachycardia to map and ablate the arrhythmia, a newer, safer, and more effective approach is used. A 3-D anatomic map is constructed of the left ventricle to identify areas of myocardial scar that give rise to arrhythmia. Ablation lesions are administered in the "borderzone" between the scar and normal tissues. Patients who are intolerant of antiarrhythmic drugs, or who undergo frequent shocks from implantable cardioverter defibrillator therapy, can benefit from this procedure. read more

 Back to Top



Important Note:

The Stony Brook Medicine University Physicians website is primarily an informational and educational resource. It should not be used in place of medical advice and recommendations you receive from your health care provider. If you have, or suspect that you have a medical problem or condition, please seek the advice of your health care provider.


Stony Brook Medicine University Physicians provides marketing advice and consultation to the clinical Faculty associated with the University Faculty Practice Corporations (UFPCs). It does not provide medical care directly or indirectly nor does it oversee, direct, manage or supervise the medical care provided by any of the individual Practices. The individual Practices are responsible for the medical care each Practice provides to its patients. Please note that the Practices listed below are separate University Faculty Practice Corporations (UFPCs).